10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

APLT (Applied Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Applied Therapeutics Inc together

I guess you are interested in Applied Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Applied Therapeutics Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Applied Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Applied Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Applied Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Applied Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.8%

What is your share worth?

Current worth
$0.25
Expected worth in 1 year
$0.03
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
$-0.22
Return On Investment
-53.6%

For what price can you sell your share?

Current Price per Share
$0.41
Expected price per share
$0.303 - $0.638
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Applied Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.41
Intrinsic Value Per Share
$-5.10 - $-5.91
Total Value Per Share
$-4.85 - $-5.66

2.2. Growth of Applied Therapeutics Inc (5 min.)




Is Applied Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$36.6m$8.6m$34.2m79.8%

How much money is Applied Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$10.8m-$48.3m$37.5m344.9%
Net Profit Margin532,072.6%-9,632.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Applied Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#445 / 872

Most Revenue
#574 / 872

Most Profit
#536 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Applied Therapeutics Inc?

Welcome investor! Applied Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Applied Therapeutics Inc.

First you should know what it really means to hold a share of Applied Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied Therapeutics Inc is $0.4141. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.25. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-36.4%-0.08-18.3%-0.34-82.5%-0.19-45.7%-0.19-45.3%-0.16-39.1%
Usd Book Value Change Per Share-0.15-36.1%-0.06-13.4%0.1330.4%0.00-0.9%-0.04-10.2%0.012.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.15-36.1%-0.06-13.4%0.1330.4%0.00-0.9%-0.04-10.2%0.012.4%
Usd Price Per Share0.49-3.63-3.48-2.66-8.90-9.89-
Price to Earnings Ratio-0.81-13.13--2.41-3.01--7.92--14.52-
Price-to-Total Gains Ratio-3.27-27.67--202.63--62.48--72.16-21.66-
Price to Book Ratio1.93-54.36--21.77-12.29-17.68-22.37-
Price-to-Total Gains Ratio-3.27-27.67--202.63--62.48--72.16-21.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4141
Number of shares2414
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.06-0.04
Usd Total Gains Per Share-0.06-0.04
Gains per Quarter (2414 shares)-134.02-102.25
Gains per Year (2414 shares)-536.07-409.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-536-5460-409-419
20-1072-10820-818-828
30-1608-16180-1227-1237
40-2144-21541-1637-1646
50-2680-26901-2046-2055
60-3216-32261-2455-2464
70-3752-37621-2864-2873
80-4289-42981-3273-3282
90-4825-48341-3682-3691
100-5361-53701-4091-4100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%2.024.00.07.7%2.024.00.07.7%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%8.018.00.030.8%8.018.00.030.8%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.025.03.8%1.00.025.03.8%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%8.018.00.030.8%8.018.00.030.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Applied Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.149-0.056-63%0.126-219%-0.004-98%-0.042-72%0.010-1634%
Book Value Per Share--0.2530.302-16%0.061+312%0.142+78%0.352-28%0.338-25%
Current Ratio--3.0042.357+27%1.068+181%1.531+96%3.032-1%3.965-24%
Debt To Asset Ratio--0.3560.519-31%1.053-66%0.818-57%0.579-39%0.583-39%
Debt To Equity Ratio--0.5524.731-88%0.312+77%2.961-81%1.895-71%1.504-63%
Dividend Per Share----0%-0%0.000-100%0.000-100%0.000-100%
Enterprise Value--101309853.200530600536.100-81%495013730.000-80%382629307.367-74%1297808646.420-92%1558210505.350-93%
Eps---0.151-0.076-50%-0.342+127%-0.189+25%-0.188+25%-0.162+7%
Ev To Ebitda Ratio---0.996-6.696+572%-6.376+540%-4.804+382%-13.370+1242%-20.775+1985%
Ev To Sales Ratio---25327.463-7200.451-72%589.769-4394%-3403.231-87%-3403.231-87%-3403.231-87%
Free Cash Flow Per Share---0.198-0.165-17%-0.118-40%-0.130-34%-0.140-29%-0.124-37%
Free Cash Flow To Equity Per Share---0.198-0.168-15%0.218-191%-0.003-99%-0.036-82%0.013-1622%
Gross Profit Margin--1.0000.989+1%1.0000%0.996+0%0.998+0%0.998+0%
Intrinsic Value_10Y_max---5.915----------
Intrinsic Value_10Y_min---5.099----------
Intrinsic Value_1Y_max---0.532----------
Intrinsic Value_1Y_min---0.522----------
Intrinsic Value_3Y_max---1.644----------
Intrinsic Value_3Y_min---1.569----------
Intrinsic Value_5Y_max---2.813----------
Intrinsic Value_5Y_min---2.607----------
Market Cap58626621.600-21%70786853.200514140036.100-86%492684480.000-86%376299474.033-81%1260098546.420-94%1400568851.092-95%
Net Profit Margin--21825.0005320.726+310%-96.322+100%1741.389+1153%1044.833+1989%803.718+2616%
Operating Margin--25525.0006284.815+306%-19.879+100%2088.227+1122%1252.936+1937%963.797+2548%
Operating Ratio---25605.000-6304.315-75%20.406-125575%-2094.467-92%-1256.680-95%-966.677-96%
Pb Ratio1.635-18%1.93054.358-96%-21.772+1228%12.293-84%17.685-89%22.369-91%
Pe Ratio-0.687+15%-0.81113.132-106%-2.406+197%3.012-127%-7.923+877%-14.525+1691%
Price Per Share0.414-18%0.4893.629-87%3.480-86%2.657-82%8.900-95%9.892-95%
Price To Free Cash Flow Ratio-0.523+15%-0.618-5.596+806%-7.110+1050%-5.012+711%-16.045+2496%-20.843+3273%
Price To Total Gains Ratio-2.772+15%-3.27227.673-112%-202.633+6092%-62.479+1809%-72.162+2105%21.661-115%
Quick Ratio--2.8261.510+87%0.974+190%1.225+131%3.490-19%4.625-39%
Return On Assets---0.384-0.124-68%-0.714+86%-0.385+0%-0.325-15%-0.318-17%
Return On Equity---0.595-2.856+380%-0.312-48%-1.449+143%-0.995+67%-0.827+39%
Total Gains Per Share---0.149-0.056-63%0.126-219%-0.004-98%-0.042-72%0.010-1632%
Usd Book Value--36668000.00042989500.000-15%8692500.000+322%20179500.000+82%49805050.000-26%47814923.077-23%
Usd Book Value Change Per Share---0.149-0.056-63%0.126-219%-0.004-98%-0.042-72%0.010-1634%
Usd Book Value Per Share--0.2530.302-16%0.061+312%0.142+78%0.352-28%0.338-25%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%0.000-100%
Usd Enterprise Value--101309853.200530600536.100-81%495013730.000-80%382629307.367-74%1297808646.420-92%1558210505.350-93%
Usd Eps---0.151-0.076-50%-0.342+127%-0.189+25%-0.188+25%-0.162+7%
Usd Free Cash Flow---28636000.000-23507500.000-18%-16773500.000-41%-18483083.333-35%-19814450.000-31%-17589230.769-39%
Usd Free Cash Flow Per Share---0.198-0.165-17%-0.118-40%-0.130-34%-0.140-29%-0.124-37%
Usd Free Cash Flow To Equity Per Share---0.198-0.168-15%0.218-191%-0.003-99%-0.036-82%0.013-1622%
Usd Market Cap58626621.600-21%70786853.200514140036.100-86%492684480.000-86%376299474.033-81%1260098546.420-94%1400568851.092-95%
Usd Price Per Share0.414-18%0.4893.629-87%3.480-86%2.657-82%8.900-95%9.892-95%
Usd Profit---21825000.000-10877750.000-50%-48391000.000+122%-25514166.667+17%-25820550.000+18%-22346615.385+2%
Usd Revenue---1000.00066250.000-102%-119250.000+11825%870666.667-100%522400.000-100%401846.154-100%
Usd Total Gains Per Share---0.149-0.056-63%0.126-219%-0.004-98%-0.042-72%0.010-1632%
 EOD+3 -5MRQTTM+13 -25YOY+17 -203Y+21 -195Y+14 -2610Y+13 -27

3.3 Fundamental Score

Let's check the fundamental score of Applied Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.687
Price to Book Ratio (EOD)Between0-11.635
Net Profit Margin (MRQ)Greater than021,825.000
Operating Margin (MRQ)Greater than025,525.000
Quick Ratio (MRQ)Greater than12.826
Current Ratio (MRQ)Greater than13.004
Debt to Asset Ratio (MRQ)Less than10.356
Debt to Equity Ratio (MRQ)Less than10.552
Return on Equity (MRQ)Greater than0.15-0.595
Return on Assets (MRQ)Greater than0.05-0.384
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.880
Ma 20Greater thanMa 500.350
Ma 50Greater thanMa 1000.388
Ma 100Greater thanMa 2000.429
OpenGreater thanClose0.395
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-07-10 20:54:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Applied Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 2,182,500.0% means that $21,825.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied Therapeutics Inc:

  • The MRQ is 2,182,500.0%. The company is making a huge profit. +2
  • The TTM is 532,072.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ2,182,500.0%TTM532,072.6%+1,650,427.4%
TTM532,072.6%YOY-9,632.2%+541,704.8%
TTM532,072.6%5Y104,483.3%+427,589.3%
5Y104,483.3%10Y80,371.8%+24,111.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2,182,500.0%-92.7%+2,182,592.7%
TTM532,072.6%-140.3%+532,212.9%
YOY-9,632.2%-196.4%-9,435.8%
3Y174,138.9%-248.5%+174,387.4%
5Y104,483.3%-343.4%+104,826.7%
10Y80,371.8%-496.2%+80,868.0%
4.3.1.2. Return on Assets

Shows how efficient Applied Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • -38.4% Return on Assets means that Applied Therapeutics Inc generated $-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied Therapeutics Inc:

  • The MRQ is -38.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.4%TTM-12.4%-25.9%
TTM-12.4%YOY-71.4%+59.0%
TTM-12.4%5Y-32.5%+20.1%
5Y-32.5%10Y-31.8%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.4%-11.6%-26.8%
TTM-12.4%-11.6%-0.8%
YOY-71.4%-11.4%-60.0%
3Y-38.5%-11.8%-26.7%
5Y-32.5%-12.0%-20.5%
10Y-31.8%-13.7%-18.1%
4.3.1.3. Return on Equity

Shows how efficient Applied Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • -59.5% Return on Equity means Applied Therapeutics Inc generated $-0.60 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied Therapeutics Inc:

  • The MRQ is -59.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -285.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.5%TTM-285.6%+226.1%
TTM-285.6%YOY-31.2%-254.4%
TTM-285.6%5Y-99.5%-186.1%
5Y-99.5%10Y-82.7%-16.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.5%-13.6%-45.9%
TTM-285.6%-15.0%-270.6%
YOY-31.2%-14.5%-16.7%
3Y-144.9%-16.9%-128.0%
5Y-99.5%-17.5%-82.0%
10Y-82.7%-19.9%-62.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Applied Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Applied Therapeutics Inc is operating .

  • Measures how much profit Applied Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 2,552,500.0% means the company generated $25,525.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied Therapeutics Inc:

  • The MRQ is 2,552,500.0%. The company is operating very efficient. +2
  • The TTM is 628,481.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ2,552,500.0%TTM628,481.5%+1,924,018.5%
TTM628,481.5%YOY-1,987.9%+630,469.4%
TTM628,481.5%5Y125,293.6%+503,187.9%
5Y125,293.6%10Y96,379.7%+28,913.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2,552,500.0%-229.2%+2,552,729.2%
TTM628,481.5%-249.0%+628,730.5%
YOY-1,987.9%-208.5%-1,779.4%
3Y208,822.7%-223.8%+209,046.5%
5Y125,293.6%-346.1%+125,639.7%
10Y96,379.7%-475.5%+96,855.2%
4.3.2.2. Operating Ratio

Measures how efficient Applied Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of -25,605.00 means that the operating costs are $-25,605.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied Therapeutics Inc:

  • The MRQ is -25,605.000.
  • The TTM is -6,304.315.
Trends
Current periodCompared to+/- 
MRQ-25,605.000TTM-6,304.315-19,300.685
TTM-6,304.315YOY20.406-6,324.722
TTM-6,304.3155Y-1,256.680-5,047.635
5Y-1,256.68010Y-966.677-290.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25,605.0002.110-25,607.110
TTM-6,304.3152.684-6,306.999
YOY20.4063.096+17.310
3Y-2,094.4673.652-2,098.119
5Y-1,256.6804.745-1,261.425
10Y-966.6776.614-973.291
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Applied Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.00 means the company has $3.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 3.004. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.357. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.004TTM2.357+0.646
TTM2.357YOY1.068+1.290
TTM2.3575Y3.032-0.675
5Y3.03210Y3.965-0.932
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0043.661-0.657
TTM2.3573.846-1.489
YOY1.0684.140-3.072
3Y1.5314.688-3.157
5Y3.0325.746-2.714
10Y3.9656.147-2.182
4.4.3.2. Quick Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2.83 means the company can pay off $2.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 2.826. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.510. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.826TTM1.510+1.316
TTM1.510YOY0.974+0.535
TTM1.5105Y3.490-1.980
5Y3.49010Y4.625-1.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8262.8260.000
TTM1.5103.182-1.672
YOY0.9743.786-2.812
3Y1.2254.311-3.086
5Y3.4905.703-2.213
10Y4.6256.454-1.829
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Applied Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Applied Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Applied Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Applied Therapeutics Inc assets are financed with 35.6% credit (debt) and the remaining percentage (100% - 35.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.356. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.519. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.356TTM0.519-0.163
TTM0.519YOY1.053-0.534
TTM0.5195Y0.579-0.060
5Y0.57910Y0.583-0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3560.329+0.027
TTM0.5190.349+0.170
YOY1.0530.331+0.722
3Y0.8180.340+0.478
5Y0.5790.349+0.230
10Y0.5830.379+0.204
4.5.4.2. Debt to Equity Ratio

Measures if Applied Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 55.2% means that company has $0.55 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.552. The company is very able to pay all its debts with equity. +2
  • The TTM is 4.731. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ0.552TTM4.731-4.179
TTM4.731YOY0.312+4.419
TTM4.7315Y1.895+2.836
5Y1.89510Y1.504+0.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5520.379+0.173
TTM4.7310.437+4.294
YOY0.3120.414-0.102
3Y2.9610.450+2.511
5Y1.8950.464+1.431
10Y1.5040.515+0.989
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Applied Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.81 means the investor is paying $-0.81 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied Therapeutics Inc:

  • The EOD is -0.687. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.811. Based on the earnings, the company is expensive. -2
  • The TTM is 13.132. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-0.687MRQ-0.811+0.124
MRQ-0.811TTM13.132-13.943
TTM13.132YOY-2.406+15.538
TTM13.1325Y-7.923+21.055
5Y-7.92310Y-14.525+6.601
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.687-2.304+1.617
MRQ-0.811-2.080+1.269
TTM13.132-2.564+15.696
YOY-2.406-3.764+1.358
3Y3.012-3.773+6.785
5Y-7.923-6.193-1.730
10Y-14.525-6.833-7.692
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied Therapeutics Inc:

  • The EOD is -0.523. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.618. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.596. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.523MRQ-0.618+0.095
MRQ-0.618TTM-5.596+4.978
TTM-5.596YOY-7.110+1.513
TTM-5.5965Y-16.045+10.449
5Y-16.04510Y-20.843+4.797
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.523-3.132+2.609
MRQ-0.618-2.705+2.087
TTM-5.596-3.666-1.930
YOY-7.110-4.405-2.705
3Y-5.012-5.059+0.047
5Y-16.045-8.477-7.568
10Y-20.843-9.304-11.539
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Applied Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.93 means the investor is paying $1.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied Therapeutics Inc:

  • The EOD is 1.635. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.930. Based on the equity, the company is underpriced. +1
  • The TTM is 54.358. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.635MRQ1.930-0.295
MRQ1.930TTM54.358-52.428
TTM54.358YOY-21.772+76.130
TTM54.3585Y17.685+36.673
5Y17.68510Y22.369-4.685
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6351.953-0.318
MRQ1.9301.843+0.087
TTM54.3582.112+52.246
YOY-21.7722.441-24.213
3Y12.2932.494+9.799
5Y17.6853.661+14.024
10Y22.3694.311+18.058
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied Therapeutics Inc.

4.8.1. Institutions holding Applied Therapeutics Inc

Institutions are holding 83.045% of the shares of Applied Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vestal Point Capital LP8.12290.40151150000000
2025-03-31Propel Bio Management LLC7.97136.410211285420167000017.3679
2025-03-31T. Rowe Price Investment Management,Inc.7.33220.003410380590495967091.4913
2025-03-31BlackRock Inc6.74640.000195513022552272.7455
2025-03-31Knoll Capital Management LP5.50922.4767799687200000034.4846
2025-03-31Vanguard Group Inc4.15980.000158891933409626.1454
2025-03-31VR Adviser, LLC3.93270.23165567709-4422882-44.2705
2025-03-31Schonfeld Strategic Advisors LLC3.30110.01384673613-4088678-46.6622
2025-03-31Simplify Asset Management Inc.3.16970.08224487505167000059.2723
2025-03-31Deutsche Bank AG3.15490.00094466585-1537-0.0344
2025-03-31Alyeska Investment Group, L.P.2.19490.0061310749740000014.7738
2025-03-31Morgan Stanley - Brokerage Accounts2.02880.00012872224-5943556-67.4195
2025-03-31TANG CAPITAL MANAGEMENT LLC1.71510.0657242816900
2025-03-31Geode Capital Management, LLC1.51960.00012151392672503.2267
2025-03-31Rock Springs Capital Management LP1.46560.05820748911577008.2256
2025-03-31Franklin Resources Inc1.4150.00032003338-62-0.0031
2025-03-31Adage Capital Partners Gp LLC1.38560.0018196162900
2025-03-31State Street Corp1.37801950909-115427-5.5861
2025-03-31Qube Research & Technologies1.36960.00111939004-11517-0.5905
2025-03-31Marshall Wace Asset Management Ltd0.92350.0008130738100
Total 68.79599.753897398038-3062850-3.1%

4.9.2. Funds holding Applied Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31T. Rowe Price Small-Cap Value4.57020.03316470223-1391-0.0215
2025-05-31Simplify Propel Opportunities ETF3.16972.4974448750500
2025-03-31T. Rowe Price U.S. SC Value Eq Tr-D2.57590.03183646845176296493.5815
2025-05-31Vanguard Total Stock Mkt Idx Inv2.19280.0001310443500
2025-05-31iShares Russell 2000 ETF2.00990.0016284553100
2025-05-31Franklin Biotechnology Discv A(acc)USD0.89210.0357126304800
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.89060.0004126093800
2025-03-31Fidelity Small Cap Index0.69590.00298519800
2025-05-31Franklin Biotechnology Discovery A0.52280.038674020000
2025-05-31Xtrackers S&P 500 Swap ETF 1C0.43950.002262222700
2025-05-31iShares Biotechnology ETF0.42890.004360723800
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.4060.000557479400
2025-05-31iShares Russell 2000 Growth ETF0.35320.001650002700
2025-03-31HBM Healthcare Investments AG Ord0.35320.012250000000
2025-05-31Vanguard Russell 2000 ETF0.34160.001448363543990.9179
2025-04-30Fidelity Extended Market Index0.34120.0006483020-4617-0.9468
2025-05-31Schwab US Small-Cap ETF™0.28620.0009405138-1073-0.2641
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.24010.001433990000
2025-05-31iShares Russell 2000 Value ETF0.23860.001133786200
2025-03-31Vanguard Strategic Small-Cap Equity Inv0.18880.0082672482672480
Total 21.13722.674929925012+2027530+6.8%

5.3. Insider Transactions

Insiders are holding 5.49% of the shares of Applied Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-04Riccardo PerfettiSELL103660.44
2025-02-06Leslie D FuntleyderSELL229500.61
2024-08-14Shoshana ShendelmanSELL1195915.93
2024-08-12Shoshana ShendelmanSELL3000005.98
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets56,907
Total Liabilities20,239
Total Stockholder Equity36,668
 As reported
Total Liabilities 20,239
Total Stockholder Equity+ 36,668
Total Assets = 56,907

Assets

Total Assets56,907
Total Current Assets53,966
Long-term Assets2,941
Total Current Assets
Cash And Cash Equivalents 50,762
Other Current Assets 3,204
Total Current Assets  (as reported)53,966
Total Current Assets  (calculated)53,966
+/-0
Long-term Assets
Property Plant Equipment 2,688
Long-term Assets Other 253
Long-term Assets  (as reported)2,941
Long-term Assets  (calculated)2,941
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,965
Long-term Liabilities2,274
Total Stockholder Equity36,668
Total Current Liabilities
Short-term Debt 426
Accounts payable 4,868
Other Current Liabilities 7,803
Total Current Liabilities  (as reported)17,965
Total Current Liabilities  (calculated)13,097
+/- 4,868
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,274
Long-term Liabilities  (as reported)2,274
Long-term Liabilities  (calculated)2,274
+/-0
Total Stockholder Equity
Common Stock35
Retained Earnings -596,035
Other Stockholders Equity 632,668
Total Stockholder Equity (as reported)36,668
Total Stockholder Equity (calculated)36,668
+/-0
Other
Capital Stock35
Cash and Short Term Investments 50,762
Common Stock Shares Outstanding 144,788
Current Deferred Revenue212
Liabilities and Stockholders Equity 56,907
Net Debt -48,062
Net Invested Capital 36,668
Net Working Capital 36,001
Property Plant and Equipment Gross 2,688
Short Long Term Debt Total 2,700



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
20,246
16,872
46,784
37,264
48,389
165,882
150,572
124,838
104,506
156,219
136,959
118,547
89,892
64,953
78,178
56,679
38,363
30,004
43,646
45,195
54,833
151,234
127,778
106,566
86,691
56,907
56,90786,691106,566127,778151,23454,83345,19543,64630,00438,36356,67978,17864,95389,892118,547136,959156,219104,506124,838150,572165,88248,38937,26446,78416,87220,246000
   > Total Current Assets 
3,277
0
0
20,246
16,872
46,784
37,034
46,155
163,741
148,524
122,885
102,593
154,406
135,250
116,943
88,394
63,564
76,898
55,510
37,308
29,063
42,821
44,488
54,386
150,906
127,572
104,603
83,646
53,966
53,96683,646104,603127,572150,90654,38644,48842,82129,06337,30855,51076,89863,56488,394116,943135,250154,406102,593122,885148,524163,74146,15537,03446,78416,87220,246003,277
       Cash And Cash Equivalents 
-3,277
0
0
18,748
14,686
41,076
13,065
18,850
92,503
100,854
48,679
57,466
84,067
78,434
70,207
53,888
38,214
55,728
40,388
16,657
22,917
35,616
37,457
49,898
146,484
122,197
98,867
79,398
50,762
50,76279,39898,867122,197146,48449,89837,45735,61622,91716,65740,38855,72838,21453,88870,20778,43484,06757,46648,679100,85492,50318,85013,06541,07614,68618,74800-3,277
       Short-term Investments 
6,554
0
0
0
0
0
19,889
20,004
61,806
37,644
67,826
39,363
63,992
47,182
38,595
26,935
17,437
11,994
6,990
13,923
0
0
0
0
253
0
0
0
0
0000253000013,9236,99011,99417,43726,93538,59547,18263,99239,36367,82637,64461,80620,00419,889000006,554
       Net Receivables 
0
0
0
0
0
0
0
0
136
33
37
505
591
335
327
525
492
288
276
275
285
285
285
285
262
262
262
0
0
00262262262285285285285275276288492525327335591505373313600000000
       Other Current Assets 
0
0
0
1,498
2,834
5,708
4,080
7,301
9,296
9,993
6,343
5,259
5,756
9,299
7,814
7,046
7,421
8,888
7,856
6,453
5,861
6,920
6,746
920
4,160
5,113
2,955
461
3,204
3,2044612,9555,1134,1609206,7466,9205,8616,4537,8568,8887,4217,0467,8149,2995,7565,2596,3439,9939,2967,3014,0805,7082,8341,498000
   > Long-term Assets 
-3,277
0
0
0
0
0
230
2,234
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
328
206
1,963
3,045
2,941
2,9413,0451,9632063284477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,23423000000-3,277
       Property Plant Equipment 
0
0
0
0
0
0
0
2,035
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
328
206
1,963
2,792
2,688
2,6882,7921,9632063284477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,0350000000
       Long Term Investments 
0
0
0
0
0
0
0
199
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001990000000
       Long-term Assets Other 
-3,277
0
0
0
0
0
230
199
199
199
199
0
201
201
200
-26,935
199
199
199
198
198
197
197
0
0
0
0
0
253
25300000197197198198199199199-26,935200201201019919919919923000000-3,277
> Total Liabilities 
0
0
0
4,428
44,789
6,780
6,517
15,782
10,054
20,368
21,898
22,567
20,998
24,519
31,846
27,353
22,990
52,370
47,050
34,302
34,076
47,980
56,239
71,979
83,940
55,386
100,674
29,685
20,239
20,23929,685100,67455,38683,94071,97956,23947,98034,07634,30247,05052,37022,99027,35331,84624,51920,99822,56721,89820,36810,05415,7826,5176,78044,7894,428000
   > Total Current Liabilities 
0
0
0
4,428
6,328
6,780
6,517
14,099
8,466
18,876
20,502
21,235
19,774
23,405
30,843
26,462
22,217
51,715
46,514
33,424
33,251
47,188
55,504
71,182
83,905
55,356
98,967
27,296
17,965
17,96527,29698,96755,35683,90571,18255,50447,18833,25133,42446,51451,71522,21726,46230,84323,40519,77421,23520,50218,8768,46614,0996,5176,7806,3284,428000
       Short-term Debt 
0
0
0
0
0
0
0
356
728
3,594
760
406
830
3,584
2,410
442
906
924
2,024
1,099
483
1,726
1,266
739
308
370
264
0
426
42602643703087391,2661,7264831,0992,0249249064422,4103,5848304067603,5947283560000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
3,222
2,148
1,074
0
3,158
1,974
789
0
2,487
1,554
622
0
1,240
775
310
0
0
0
0
0
000003107751,24006221,5542,48707891,9743,15801,0742,1483,222000000000
       Accounts payable 
0
0
0
3,015
2,649
3,987
1,688
8,793
1,606
5,649
1,945
640
3,475
3,310
9,170
9,461
5,922
8,691
6,973
4,534
5,555
4,687
6,005
1,742
4,019
2,683
2,837
4,433
4,868
4,8684,4332,8372,6834,0191,7426,0054,6875,5554,5346,9738,6915,9229,4619,1703,3103,4756401,9455,6491,6068,7931,6883,9872,6493,015000
       Other Current Liabilities 
0
0
0
1,413
3,679
2,793
4,829
4,950
6,132
9,633
17,797
20,189
15,469
16,511
19,263
16,559
15,389
42,100
37,517
27,791
27,213
40,775
48,233
68,034
79,101
51,970
95,654
6,917
7,803
7,8036,91795,65451,97079,10168,03448,23340,77527,21327,79137,51742,10015,38916,55919,26316,51115,46920,18917,7979,6336,1324,9504,8292,7933,6791,413000
   > Long-term Liabilities 
0
0
0
0
38,461
38,461
0
1,683
1,588
1,492
1,396
1,332
1,224
1,114
1,003
891
773
655
536
878
825
792
735
797
35
30
1,707
2,389
2,274
2,2742,3891,70730357977357928258785366557738911,0031,1141,2241,3321,3961,4921,5881,683038,46138,4610000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
622
0
0
0
0
0
0
0
0000000622000000000000000000000
> Total Stockholder Equity
2,293
0
0
15,818
-27,917
40,004
30,747
32,607
155,828
130,204
102,940
81,939
135,221
112,440
86,701
62,539
41,963
25,808
9,629
4,061
-4,072
-4,334
-11,044
-17,146
67,294
72,392
5,892
57,006
36,668
36,66857,0065,89272,39267,294-17,146-11,044-4,334-4,0724,0619,62925,80841,96362,53986,701112,440135,22181,939102,940130,204155,82832,60730,74740,004-27,91715,818002,293
   Common Stock
0
0
0
0
0
1
1
1
2
2
2
2
3
3
3
3
3
5
5
5
5
6
7
8
11
11
11
0
35
350111111876555533333222211100000
   Retained Earnings -596,035-574,210-618,217-549,626-552,524-468,586-430,907-388,537-358,960-348,823-334,394-315,293-289,436-266,315-239,156-210,738-184,910-160,731-137,042-107,198-79,139-66,770-49,137-38,424-29,987-21,257000
   Capital Surplus 
0
0
0
0
2,070
78,427
79,872
99,378
234,876
0
0
242,780
320,282
323,360
326,108
0
0
0
0
0
354,883
384,197
0
0
0
0
0
0
0
0000000384,197354,88300000326,108323,360320,282242,78000234,87699,37879,87278,4272,0700000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,665
2,070
31,643
79,872
99,378
234,876
237,429
240,074
242,780
320,282
323,360
326,108
328,958
331,476
341,090
343,995
352,828
354,883
384,197
419,856
451,432
619,807
622,007
624,098
0
632,668
632,6680624,098622,007619,807451,432419,856384,197354,883352,828343,995341,090331,476328,958326,108323,360320,282242,780240,074237,429234,87699,37879,87231,6432,0701,665000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue455
Cost of Revenue-425
Gross Profit3030
 
Operating Income (+$)
Gross Profit30
Operating Expense-104,754
Operating Income-104,299-104,724
 
Operating Expense (+$)
Research Development48,744
Selling General Administrative56,010
Selling And Marketing Expenses0
Operating Expense104,754104,754
 
Net Interest Income (+$)
Interest Income3,534
Interest Expense-0
Other Finance Cost-0
Net Interest Income3,534
 
Pretax Income (+$)
Operating Income-104,299
Net Interest Income3,534
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-105,624-102,974
EBIT - interestExpense = -104,299
-105,624
-105,624
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-104,299-105,624
Earnings Before Interest and Taxes (EBITDA)-103,873
 
After tax Income (+$)
Income Before Tax-105,624
Tax Provision-0
Net Income From Continuing Ops-105,624-105,624
Net Income-105,624
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses104,754
Total Other Income/Expenses Net-1,325-3,534
 

Technical Analysis of Applied Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Applied Therapeutics Inc. The general trend of Applied Therapeutics Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Applied Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Applied Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Applied Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.6099 < 0.6199 < 0.638.

The bearish price targets are: 0.41 > 0.39 > 0.303.

Know someone who trades $APLT? Share this with them.👇

Applied Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Applied Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Applied Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Applied Therapeutics Inc. The current macd is -0.00246755.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Applied Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Applied Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Applied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartApplied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Applied Therapeutics Inc. The current adx is 12.84.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Applied Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Applied Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Applied Therapeutics Inc. The current sar is 0.30484.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Applied Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Applied Therapeutics Inc. The current rsi is 58.88. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Applied Therapeutics Inc Daily Relative Strength Index (RSI) ChartApplied Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Applied Therapeutics Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied Therapeutics Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Applied Therapeutics Inc Daily Stochastic Oscillator ChartApplied Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Applied Therapeutics Inc. The current cci is 193.50.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Applied Therapeutics Inc Daily Commodity Channel Index (CCI) ChartApplied Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Applied Therapeutics Inc. The current cmo is 31.55.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Applied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartApplied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Applied Therapeutics Inc. The current willr is -0.78125.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Applied Therapeutics Inc Daily Williams %R ChartApplied Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Applied Therapeutics Inc.

Applied Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Applied Therapeutics Inc. The current atr is 0.03586011.

Applied Therapeutics Inc Daily Average True Range (ATR) ChartApplied Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Applied Therapeutics Inc. The current obv is -100,593,823.

Applied Therapeutics Inc Daily On-Balance Volume (OBV) ChartApplied Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Applied Therapeutics Inc. The current mfi is 44.43.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Applied Therapeutics Inc Daily Money Flow Index (MFI) ChartApplied Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Applied Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Applied Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.880
Ma 20Greater thanMa 500.350
Ma 50Greater thanMa 1000.388
Ma 100Greater thanMa 2000.429
OpenGreater thanClose0.395
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Applied Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Applied Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Applied Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Applied Therapeutics Inc.

Receive notifications about Applied Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.